Luye Pharma Group Ltd. (HKG:2186)

Hong Kong · Delayed Price · Currency is HKD

2.700

+0.030 (1.12%)

Feb 13, 2026, 4:08 PM HKT

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005
Oncology Drugs	2.26B
Oncology Drugs Growth	-3.63%
Cardiovascular System Drugs	1.80B
Cardiovascular System Drugs Growth	-3.47%
Central Nervous System Drugs	1.75B
Central Nervous System Drugs Growth	-6.59%
Alimentary Tract and Metabolism Drugs	421.63M
Alimentary Tract and Metabolism Drugs Growth	-15.29%
Other	341.18M
Other Growth	63.98%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005
China	5.34B
China Growth	-3.93%
European Union	636.08M
European Union Growth	27.93%
Asia	376.75M
Asia Growth	-23.68%
Other Countries	219.74M
Other Countries Growth	-8.27%